New Parent Concerns: Baby Reflux and GORD

Clinical Scenario

Oliver Thompson is 11 weeks old. His mother, a first-time parent, calls because Oliver has persistent milk regurgitation, post-feed discomfort with crying and back-arching, and is not improving on Gaviscon Infant (started 2 weeks ago). Oliver was born at term, is exclusively breastfed, and has mild eczema. He is gaining weight well (5.5kg to 5.7kg in 2 weeks). His mother has eczema and his paternal aunt has asthma. The mother is exhausted, anxious, and feeling like she is failing as a parent because she cannot soothe her baby after feeds.

What This Case Tests

Differentiating simple possetting from GORD; assessing for red flags requiring urgent referral (projectile vomiting, bilious vomiting, blood, failure to thrive); recognising when to consider CMPA as a differential in an infant with eczema and family atopy; stepping up reflux management from Gaviscon to ranitidine or PPI; identifying and addressing new parent anxiety as a clinical concern in its own right.

Common Mistakes Trainees Make

The three most common mistakes are: jumping to a CMPA diagnosis based on eczema and family atopy alone (without adequate assessment of CMPA-specific features), escalating to PPI medication without first confirming that Gaviscon was used correctly and consistently, and focusing entirely on the baby without addressing the mother's emotional state — a first-time parent who feels she is failing needs support that goes beyond medical management.

The Consultation Challenge

This consultation has two patients: Oliver and his mother. The medical management of reflux is important, but the mother's emotional state is equally so. A first-time parent who cannot soothe her baby after feeds, who is exhausted, and who feels she is failing needs validation and reassurance alongside a clinical management plan.

Start with the baby. Take a structured reflux history: when did symptoms start (reflux from the first week is typical of GORD), what happens during and after feeds (milk returning, crying, back-arching), how often, any associated symptoms (blood in vomit, bile staining, projectile vomiting — all red flags), feeding pattern (is Oliver refusing the breast or still feeding eagerly?), and weight trajectory (the single most important indicator of severity).

The good news in this case is the weight gain. Oliver is growing well, which means whatever distress the reflux is causing, he is getting adequate nutrition. This is reassuring for the mother and clinically important.

Gaviscon has not worked after 2 weeks. Before stepping up treatment, check it was used correctly: mixed into expressed breast milk or given on a spoon before/after feeds, at the right dose, consistently. If it has been used correctly with no improvement, stepping up to a H2 receptor antagonist (ranitidine) or PPI (omeprazole) is appropriate per NICE guidance.

The CMPA question needs careful handling. Oliver has eczema, family atopy, and GI symptoms — this raises the pre-test probability. However, his eczema is mild, his weight gain is excellent, there is no blood or mucus in his stool, and he is not refusing feeds. The current picture is more consistent with straightforward GORD, but you should discuss CMPA as a possibility if reflux treatment fails, and explain the maternal elimination diet trial as a next step if needed.

Now address the mother. Ask how she is doing. Is she sleeping? Does she have support? Is she enjoying any part of motherhood or is it all consumed by worry? Screen for postnatal mood disturbance — perinatal depression and anxiety can present as excessive health anxiety about the baby. Validate her experience: "Looking after a baby with reflux is exhausting, and it's completely normal to feel overwhelmed."

Time check: Spend the first 4 minutes on Oliver's history and red flag screening. By minute 6, explain your assessment (GORD with Gaviscon failure) and step up the treatment plan. Address the CMPA differential briefly by minute 8. Use the final 4 minutes to check on the mother's wellbeing and provide emotional support alongside the clinical follow-up plan.

How Examiners Mark This Case

Data Gathering and Diagnosis: Examiners assess whether you take a systematic reflux history including red flags (projectile vomiting suggesting pyloric stenosis, bilious vomiting, blood in vomit or stool, failure to thrive, feeding refusal). They look for weight assessment (the key differentiator between GORD and serious pathology), review of Gaviscon use (dose, technique, consistency), and screening for CMPA features. They also assess whether you screen the mother's wellbeing — a trainee who only examines the baby's problem without checking on the parent misses a key dimension.

Clinical Management and Medical Complexity: Examiners expect stepped management following NICE NG1: positioning advice, feed modification, Gaviscon, then acid suppression (ranitidine or omeprazole). They look for knowledge of when to consider CMPA (eczema plus GI symptoms plus family atopy), the elimination diet trial approach, and when to refer to paediatrics (red flags, failure to thrive, no response to treatment). Demonstrating awareness of the treatment ladder — and where Oliver sits on it — shows clinical confidence.

Relating to Others: Examiners specifically assess whether you address the mother's emotional state, validate her experience of parenting a reflux baby, and screen for postnatal mood disturbance. The mother should leave feeling reassured that Oliver is growing well, confident in the new management plan, and supported as a person — not just as a patient's carer.

Example Opening

Strong opening: "Hello, I can see you've been dealing with Oliver's reflux for a while now and the Gaviscon hasn't really helped. Before we talk about what to do next, how are you both doing? I know this has been really tough."

This immediately signals that you care about the mother as well as the baby.

When reassuring about weight: "The really positive news here is that Oliver is growing brilliantly — he's put on good weight in the last two weeks. That tells me that despite how uncomfortable the reflux is making him, he's getting all the nutrition he needs. That's important and it's reassuring."

When stepping up treatment: "The Gaviscon creates a physical barrier to stop the milk coming back up, but it doesn't reduce the acid that's causing Oliver's discomfort. I'd like to try a medicine that actually reduces the acid production — that should make a real difference to the pain and the arching."

Avoid: "Reflux is very common in babies and usually resolves by itself." (Technically true but dismissive of a mother who is struggling now).

How This Appears in the SCA

Infant reflux is a common SCA topic that tests clinical reasoning (differentiating simple reflux from GORD from CMPA), stepped management (from positioning advice to Gaviscon to acid suppression), and holistic care (assessing the parent alongside the baby). Examiners value trainees who recognise the dual patient nature of neonatal consultations.

Key Statistic

Gastro-oesophageal reflux occurs in approximately 40% of infants, with symptoms typically peaking at 4 months and resolving by 12-18 months as the oesophageal sphincter matures. Only 5-10% of infants with reflux have GORD requiring medical treatment.

Relevant Guidelines

• NICE NG1: Gastro-oesophageal reflux disease in children and young people
• NICE CG116: Food allergy in under 19s
• NICE postnatal care guidelines.

Frequently Asked Questions

What red flags should I screen for in an infant with vomiting?

Key red flags include: projectile vomiting (suggesting pyloric stenosis — typically onset at 2-8 weeks), bilious (green) vomiting (suggesting intestinal obstruction), blood in vomit or stool, faltering growth or weight loss, feeding refusal, abdominal distension, and lethargy. Any of these require urgent paediatric referral. In this case, Oliver has none — his vomiting is non-projectile, non-bilious, his weight gain is excellent, and he is still feeding.

When should I step up from Gaviscon to acid suppression for infant reflux?

If Gaviscon has been used correctly and consistently for 2 weeks without improvement, NICE recommends stepping up to a H2 receptor antagonist (ranitidine) or PPI (omeprazole). Gaviscon works as a physical barrier (thickening feeds and forming a raft on stomach contents) while acid suppressants reduce acid production. If the infant's distress is primarily acid-related (crying, back-arching, feeding pain), acid suppression is the logical next step.

How do I differentiate GORD from CMPA in an infant?

Significant overlap exists, which makes this challenging. Features more suggestive of CMPA include: eczema that is persistent or worsening, blood or mucus in stool, persistent loose stools, feeding refusal, and failure to thrive. Features more suggestive of isolated GORD: good weight gain, no blood in stool, no feeding refusal, symptoms primarily after feeds. In practice, if reflux treatment fails, a CMPA elimination trial is the next diagnostic step.

How do I screen for postnatal mood disturbance in a consultation about the baby?

Ask directly but gently: "How are you doing? Not just with Oliver, but with everything — are you sleeping when you can? Do you have support at home? Are you getting any enjoyment from being a mum, or does it feel like it's all about the reflux?" These questions normalise the difficulty while screening for depression and anxiety. If concerns arise, offer a follow-up appointment focused specifically on the mother's wellbeing.

What positioning advice should I give for a reflux baby?

Keep the baby upright for 20-30 minutes after feeds, use a slightly elevated head position for the cot (raise the mattress end, not pillows), offer smaller and more frequent feeds if tolerated, and ensure good winding during and after feeds. For breastfed babies, check latch — a poor latch can cause excessive air swallowing that worsens reflux. These practical measures should be implemented alongside any medication changes.